Ashkon Software

   







 

CGIX Stock - Cancer Genetics, Inc.


CGIX Stock Chart

CGIX Profile

Cancer Genetics, Inc. logo

Cancer Genetics, Inc. (CGIX) is a company focused on developing and commercializing innovative genomic-based diagnostic tests and services. Their products and services are designed to provide patients and physicians with better information for the diagnosis, prognosis, and treatment of cancer.

Cancer Genetics' proprietary technologies and tests are based on the analysis of cancer-related genes and biomarkers. They offer a range of tests for various cancers, including hematological malignancies, solid tumors, and women's cancers. These tests provide clinicians with valuable information that can help guide treatment decisions.

The company also provides a range of biopharma services, including biomarker discovery, assay development, clinical trial support, and companion diagnostic development. Their customers include biotech and pharmaceutical companies, as well as academic and research institutions.

Cancer Genetics hass a strong pipeline of products in development, including several new diagnostic tests for different types of cancer. They are also exploring new applications for their existing tests and technologies.

In summary, Cancer Genetics is a company that is leveraging the power of genomics to provide innovative diagnostic tests and services for cancer patients. With a strong pipeline of products in development and a growing list of customers, they are well-positioned for future growth in this impor



 

 
Copyright © 2000-2024, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer